Global Plasma-derived Medicinal Products Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.
LPI (LP Information)' newest research report, the “Plasma-derived Medicinal Products Industry Forecast” looks at past sales and reviews total world Plasma-derived Medicinal Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Plasma-derived Medicinal Products sales for 2023 through 2029. With Plasma-derived Medicinal Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasma-derived Medicinal Products industry.
This Insight Report provides a comprehensive analysis of the global Plasma-derived Medicinal Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasma-derived Medicinal Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Plasma-derived Medicinal Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasma-derived Medicinal Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasma-derived Medicinal Products.
The global Plasma-derived Medicinal Products market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Plasma-derived Medicinal Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Plasma-derived Medicinal Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Plasma-derived Medicinal Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Plasma-derived Medicinal Products players cover Novartis(CSL Limited), Biotest AG (Creat Group Corporation), Grifols SA, Sigma-Aldrich, Thermo Fisher Scientific, Octapharma AG, Takeda, Kedrion and China Biologic Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma-derived Medicinal Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Plasma-derived Medicinal Products market?
What factors are driving Plasma-derived Medicinal Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma-derived Medicinal Products market opportunities vary by end market size?
How does Plasma-derived Medicinal Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.
LPI (LP Information)' newest research report, the “Plasma-derived Medicinal Products Industry Forecast” looks at past sales and reviews total world Plasma-derived Medicinal Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Plasma-derived Medicinal Products sales for 2023 through 2029. With Plasma-derived Medicinal Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasma-derived Medicinal Products industry.
This Insight Report provides a comprehensive analysis of the global Plasma-derived Medicinal Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasma-derived Medicinal Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Plasma-derived Medicinal Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasma-derived Medicinal Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasma-derived Medicinal Products.
The global Plasma-derived Medicinal Products market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Plasma-derived Medicinal Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Plasma-derived Medicinal Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Plasma-derived Medicinal Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Plasma-derived Medicinal Products players cover Novartis(CSL Limited), Biotest AG (Creat Group Corporation), Grifols SA, Sigma-Aldrich, Thermo Fisher Scientific, Octapharma AG, Takeda, Kedrion and China Biologic Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma-derived Medicinal Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Immunoglobulins
- Coagulation Factor Concentrates
- Other
- Emergency Care
- Epidemic Diseasae
- Immune System Disorder
- Antibody Deficiency
- Coagulation Disorder
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis(CSL Limited)
- Biotest AG (Creat Group Corporation)
- Grifols SA
- Sigma-Aldrich
- Thermo Fisher Scientific
- Octapharma AG
- Takeda
- Kedrion
- China Biologic Products
- LFB Group
What is the 10-year outlook for the global Plasma-derived Medicinal Products market?
What factors are driving Plasma-derived Medicinal Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma-derived Medicinal Products market opportunities vary by end market size?
How does Plasma-derived Medicinal Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma-derived Medicinal Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Plasma-derived Medicinal Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Plasma-derived Medicinal Products by Country/Region, 2018, 2022 & 2029
2.2 Plasma-derived Medicinal Products Segment by Type
2.2.1 Immunoglobulins
2.2.2 Coagulation Factor Concentrates
2.2.3 Other
2.3 Plasma-derived Medicinal Products Sales by Type
2.3.1 Global Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
2.3.2 Global Plasma-derived Medicinal Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Plasma-derived Medicinal Products Sale Price by Type (2018-2023)
2.4 Plasma-derived Medicinal Products Segment by Application
2.4.1 Emergency Care
2.4.2 Epidemic Diseasae
2.4.3 Immune System Disorder
2.4.4 Antibody Deficiency
2.4.5 Coagulation Disorder
2.4.6 Others
2.5 Plasma-derived Medicinal Products Sales by Application
2.5.1 Global Plasma-derived Medicinal Products Sale Market Share by Application (2018-2023)
2.5.2 Global Plasma-derived Medicinal Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Plasma-derived Medicinal Products Sale Price by Application (2018-2023)
3 GLOBAL PLASMA-DERIVED MEDICINAL PRODUCTS BY COMPANY
3.1 Global Plasma-derived Medicinal Products Breakdown Data by Company
3.1.1 Global Plasma-derived Medicinal Products Annual Sales by Company (2018-2023)
3.1.2 Global Plasma-derived Medicinal Products Sales Market Share by Company (2018-2023)
3.2 Global Plasma-derived Medicinal Products Annual Revenue by Company (2018-2023)
3.2.1 Global Plasma-derived Medicinal Products Revenue by Company (2018-2023)
3.2.2 Global Plasma-derived Medicinal Products Revenue Market Share by Company (2018-2023)
3.3 Global Plasma-derived Medicinal Products Sale Price by Company
3.4 Key Manufacturers Plasma-derived Medicinal Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma-derived Medicinal Products Product Location Distribution
3.4.2 Players Plasma-derived Medicinal Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PLASMA-DERIVED MEDICINAL PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Plasma-derived Medicinal Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Plasma-derived Medicinal Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Plasma-derived Medicinal Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Plasma-derived Medicinal Products Market Size by Country/Region (2018-2023)
4.2.1 Global Plasma-derived Medicinal Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Plasma-derived Medicinal Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Plasma-derived Medicinal Products Sales Growth
4.4 APAC Plasma-derived Medicinal Products Sales Growth
4.5 Europe Plasma-derived Medicinal Products Sales Growth
4.6 Middle East & Africa Plasma-derived Medicinal Products Sales Growth
5 AMERICAS
5.1 Americas Plasma-derived Medicinal Products Sales by Country
5.1.1 Americas Plasma-derived Medicinal Products Sales by Country (2018-2023)
5.1.2 Americas Plasma-derived Medicinal Products Revenue by Country (2018-2023)
5.2 Americas Plasma-derived Medicinal Products Sales by Type
5.3 Americas Plasma-derived Medicinal Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma-derived Medicinal Products Sales by Region
6.1.1 APAC Plasma-derived Medicinal Products Sales by Region (2018-2023)
6.1.2 APAC Plasma-derived Medicinal Products Revenue by Region (2018-2023)
6.2 APAC Plasma-derived Medicinal Products Sales by Type
6.3 APAC Plasma-derived Medicinal Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma-derived Medicinal Products by Country
7.1.1 Europe Plasma-derived Medicinal Products Sales by Country (2018-2023)
7.1.2 Europe Plasma-derived Medicinal Products Revenue by Country (2018-2023)
7.2 Europe Plasma-derived Medicinal Products Sales by Type
7.3 Europe Plasma-derived Medicinal Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma-derived Medicinal Products by Country
8.1.1 Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Plasma-derived Medicinal Products Sales by Type
8.3 Middle East & Africa Plasma-derived Medicinal Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma-derived Medicinal Products
10.3 Manufacturing Process Analysis of Plasma-derived Medicinal Products
10.4 Industry Chain Structure of Plasma-derived Medicinal Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma-derived Medicinal Products Distributors
11.3 Plasma-derived Medicinal Products Customer
12 WORLD FORECAST REVIEW FOR PLASMA-DERIVED MEDICINAL PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Plasma-derived Medicinal Products Market Size Forecast by Region
12.1.1 Global Plasma-derived Medicinal Products Forecast by Region (2024-2029)
12.1.2 Global Plasma-derived Medicinal Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma-derived Medicinal Products Forecast by Type
12.7 Global Plasma-derived Medicinal Products Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis(CSL Limited)
13.1.1 Novartis(CSL Limited) Company Information
13.1.2 Novartis(CSL Limited) Plasma-derived Medicinal Products Product Portfolios and Specifications
13.1.3 Novartis(CSL Limited) Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis(CSL Limited) Main Business Overview
13.1.5 Novartis(CSL Limited) Latest Developments
13.2 Biotest AG (Creat Group Corporation)
13.2.1 Biotest AG (Creat Group Corporation) Company Information
13.2.2 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Portfolios and Specifications
13.2.3 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biotest AG (Creat Group Corporation) Main Business Overview
13.2.5 Biotest AG (Creat Group Corporation) Latest Developments
13.3 Grifols SA
13.3.1 Grifols SA Company Information
13.3.2 Grifols SA Plasma-derived Medicinal Products Product Portfolios and Specifications
13.3.3 Grifols SA Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grifols SA Main Business Overview
13.3.5 Grifols SA Latest Developments
13.4 Sigma-Aldrich
13.4.1 Sigma-Aldrich Company Information
13.4.2 Sigma-Aldrich Plasma-derived Medicinal Products Product Portfolios and Specifications
13.4.3 Sigma-Aldrich Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sigma-Aldrich Main Business Overview
13.4.5 Sigma-Aldrich Latest Developments
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Information
13.5.2 Thermo Fisher Scientific Plasma-derived Medicinal Products Product Portfolios and Specifications
13.5.3 Thermo Fisher Scientific Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Thermo Fisher Scientific Main Business Overview
13.5.5 Thermo Fisher Scientific Latest Developments
13.6 Octapharma AG
13.6.1 Octapharma AG Company Information
13.6.2 Octapharma AG Plasma-derived Medicinal Products Product Portfolios and Specifications
13.6.3 Octapharma AG Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Octapharma AG Main Business Overview
13.6.5 Octapharma AG Latest Developments
13.7 Takeda
13.7.1 Takeda Company Information
13.7.2 Takeda Plasma-derived Medicinal Products Product Portfolios and Specifications
13.7.3 Takeda Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takeda Main Business Overview
13.7.5 Takeda Latest Developments
13.8 Kedrion
13.8.1 Kedrion Company Information
13.8.2 Kedrion Plasma-derived Medicinal Products Product Portfolios and Specifications
13.8.3 Kedrion Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Kedrion Main Business Overview
13.8.5 Kedrion Latest Developments
13.9 China Biologic Products
13.9.1 China Biologic Products Company Information
13.9.2 China Biologic Products Plasma-derived Medicinal Products Product Portfolios and Specifications
13.9.3 China Biologic Products Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 China Biologic Products Main Business Overview
13.9.5 China Biologic Products Latest Developments
13.10 LFB Group
13.10.1 LFB Group Company Information
13.10.2 LFB Group Plasma-derived Medicinal Products Product Portfolios and Specifications
13.10.3 LFB Group Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 LFB Group Main Business Overview
13.10.5 LFB Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma-derived Medicinal Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Plasma-derived Medicinal Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Plasma-derived Medicinal Products by Country/Region, 2018, 2022 & 2029
2.2 Plasma-derived Medicinal Products Segment by Type
2.2.1 Immunoglobulins
2.2.2 Coagulation Factor Concentrates
2.2.3 Other
2.3 Plasma-derived Medicinal Products Sales by Type
2.3.1 Global Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
2.3.2 Global Plasma-derived Medicinal Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Plasma-derived Medicinal Products Sale Price by Type (2018-2023)
2.4 Plasma-derived Medicinal Products Segment by Application
2.4.1 Emergency Care
2.4.2 Epidemic Diseasae
2.4.3 Immune System Disorder
2.4.4 Antibody Deficiency
2.4.5 Coagulation Disorder
2.4.6 Others
2.5 Plasma-derived Medicinal Products Sales by Application
2.5.1 Global Plasma-derived Medicinal Products Sale Market Share by Application (2018-2023)
2.5.2 Global Plasma-derived Medicinal Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Plasma-derived Medicinal Products Sale Price by Application (2018-2023)
3 GLOBAL PLASMA-DERIVED MEDICINAL PRODUCTS BY COMPANY
3.1 Global Plasma-derived Medicinal Products Breakdown Data by Company
3.1.1 Global Plasma-derived Medicinal Products Annual Sales by Company (2018-2023)
3.1.2 Global Plasma-derived Medicinal Products Sales Market Share by Company (2018-2023)
3.2 Global Plasma-derived Medicinal Products Annual Revenue by Company (2018-2023)
3.2.1 Global Plasma-derived Medicinal Products Revenue by Company (2018-2023)
3.2.2 Global Plasma-derived Medicinal Products Revenue Market Share by Company (2018-2023)
3.3 Global Plasma-derived Medicinal Products Sale Price by Company
3.4 Key Manufacturers Plasma-derived Medicinal Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma-derived Medicinal Products Product Location Distribution
3.4.2 Players Plasma-derived Medicinal Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PLASMA-DERIVED MEDICINAL PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Plasma-derived Medicinal Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Plasma-derived Medicinal Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Plasma-derived Medicinal Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Plasma-derived Medicinal Products Market Size by Country/Region (2018-2023)
4.2.1 Global Plasma-derived Medicinal Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Plasma-derived Medicinal Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Plasma-derived Medicinal Products Sales Growth
4.4 APAC Plasma-derived Medicinal Products Sales Growth
4.5 Europe Plasma-derived Medicinal Products Sales Growth
4.6 Middle East & Africa Plasma-derived Medicinal Products Sales Growth
5 AMERICAS
5.1 Americas Plasma-derived Medicinal Products Sales by Country
5.1.1 Americas Plasma-derived Medicinal Products Sales by Country (2018-2023)
5.1.2 Americas Plasma-derived Medicinal Products Revenue by Country (2018-2023)
5.2 Americas Plasma-derived Medicinal Products Sales by Type
5.3 Americas Plasma-derived Medicinal Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma-derived Medicinal Products Sales by Region
6.1.1 APAC Plasma-derived Medicinal Products Sales by Region (2018-2023)
6.1.2 APAC Plasma-derived Medicinal Products Revenue by Region (2018-2023)
6.2 APAC Plasma-derived Medicinal Products Sales by Type
6.3 APAC Plasma-derived Medicinal Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma-derived Medicinal Products by Country
7.1.1 Europe Plasma-derived Medicinal Products Sales by Country (2018-2023)
7.1.2 Europe Plasma-derived Medicinal Products Revenue by Country (2018-2023)
7.2 Europe Plasma-derived Medicinal Products Sales by Type
7.3 Europe Plasma-derived Medicinal Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma-derived Medicinal Products by Country
8.1.1 Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Plasma-derived Medicinal Products Sales by Type
8.3 Middle East & Africa Plasma-derived Medicinal Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma-derived Medicinal Products
10.3 Manufacturing Process Analysis of Plasma-derived Medicinal Products
10.4 Industry Chain Structure of Plasma-derived Medicinal Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma-derived Medicinal Products Distributors
11.3 Plasma-derived Medicinal Products Customer
12 WORLD FORECAST REVIEW FOR PLASMA-DERIVED MEDICINAL PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Plasma-derived Medicinal Products Market Size Forecast by Region
12.1.1 Global Plasma-derived Medicinal Products Forecast by Region (2024-2029)
12.1.2 Global Plasma-derived Medicinal Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma-derived Medicinal Products Forecast by Type
12.7 Global Plasma-derived Medicinal Products Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis(CSL Limited)
13.1.1 Novartis(CSL Limited) Company Information
13.1.2 Novartis(CSL Limited) Plasma-derived Medicinal Products Product Portfolios and Specifications
13.1.3 Novartis(CSL Limited) Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis(CSL Limited) Main Business Overview
13.1.5 Novartis(CSL Limited) Latest Developments
13.2 Biotest AG (Creat Group Corporation)
13.2.1 Biotest AG (Creat Group Corporation) Company Information
13.2.2 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Portfolios and Specifications
13.2.3 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biotest AG (Creat Group Corporation) Main Business Overview
13.2.5 Biotest AG (Creat Group Corporation) Latest Developments
13.3 Grifols SA
13.3.1 Grifols SA Company Information
13.3.2 Grifols SA Plasma-derived Medicinal Products Product Portfolios and Specifications
13.3.3 Grifols SA Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grifols SA Main Business Overview
13.3.5 Grifols SA Latest Developments
13.4 Sigma-Aldrich
13.4.1 Sigma-Aldrich Company Information
13.4.2 Sigma-Aldrich Plasma-derived Medicinal Products Product Portfolios and Specifications
13.4.3 Sigma-Aldrich Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sigma-Aldrich Main Business Overview
13.4.5 Sigma-Aldrich Latest Developments
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Information
13.5.2 Thermo Fisher Scientific Plasma-derived Medicinal Products Product Portfolios and Specifications
13.5.3 Thermo Fisher Scientific Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Thermo Fisher Scientific Main Business Overview
13.5.5 Thermo Fisher Scientific Latest Developments
13.6 Octapharma AG
13.6.1 Octapharma AG Company Information
13.6.2 Octapharma AG Plasma-derived Medicinal Products Product Portfolios and Specifications
13.6.3 Octapharma AG Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Octapharma AG Main Business Overview
13.6.5 Octapharma AG Latest Developments
13.7 Takeda
13.7.1 Takeda Company Information
13.7.2 Takeda Plasma-derived Medicinal Products Product Portfolios and Specifications
13.7.3 Takeda Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takeda Main Business Overview
13.7.5 Takeda Latest Developments
13.8 Kedrion
13.8.1 Kedrion Company Information
13.8.2 Kedrion Plasma-derived Medicinal Products Product Portfolios and Specifications
13.8.3 Kedrion Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Kedrion Main Business Overview
13.8.5 Kedrion Latest Developments
13.9 China Biologic Products
13.9.1 China Biologic Products Company Information
13.9.2 China Biologic Products Plasma-derived Medicinal Products Product Portfolios and Specifications
13.9.3 China Biologic Products Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 China Biologic Products Main Business Overview
13.9.5 China Biologic Products Latest Developments
13.10 LFB Group
13.10.1 LFB Group Company Information
13.10.2 LFB Group Plasma-derived Medicinal Products Product Portfolios and Specifications
13.10.3 LFB Group Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 LFB Group Main Business Overview
13.10.5 LFB Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Plasma-derived Medicinal Products Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Plasma-derived Medicinal Products Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Immunoglobulins
Table 4. Major Players of Coagulation Factor Concentrates
Table 5. Major Players of Other
Table 6. Global Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 7. Global Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Table 8. Global Plasma-derived Medicinal Products Revenue by Type (2018-2023) & ($ million)
Table 9. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2023)
Table 10. Global Plasma-derived Medicinal Products Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 12. Global Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Table 13. Global Plasma-derived Medicinal Products Revenue by Application (2018-2023)
Table 14. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2023)
Table 15. Global Plasma-derived Medicinal Products Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Plasma-derived Medicinal Products Sales by Company (2018-2023) & (K Units)
Table 17. Global Plasma-derived Medicinal Products Sales Market Share by Company (2018-2023)
Table 18. Global Plasma-derived Medicinal Products Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Plasma-derived Medicinal Products Revenue Market Share by Company (2018-2023)
Table 20. Global Plasma-derived Medicinal Products Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Plasma-derived Medicinal Products Producing Area Distribution and Sales Area
Table 22. Players Plasma-derived Medicinal Products Products Offered
Table 23. Plasma-derived Medicinal Products Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Plasma-derived Medicinal Products Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Plasma-derived Medicinal Products Sales Market Share Geographic Region (2018-2023)
Table 28. Global Plasma-derived Medicinal Products Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Plasma-derived Medicinal Products Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Plasma-derived Medicinal Products Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Plasma-derived Medicinal Products Sales Market Share by Country/Region (2018-2023)
Table 32. Global Plasma-derived Medicinal Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Plasma-derived Medicinal Products Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Plasma-derived Medicinal Products Sales by Country (2018-2023) & (K Units)
Table 35. Americas Plasma-derived Medicinal Products Sales Market Share by Country (2018-2023)
Table 36. Americas Plasma-derived Medicinal Products Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Plasma-derived Medicinal Products Revenue Market Share by Country (2018-2023)
Table 38. Americas Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 39. Americas Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 40. APAC Plasma-derived Medicinal Products Sales by Region (2018-2023) & (K Units)
Table 41. APAC Plasma-derived Medicinal Products Sales Market Share by Region (2018-2023)
Table 42. APAC Plasma-derived Medicinal Products Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Plasma-derived Medicinal Products Revenue Market Share by Region (2018-2023)
Table 44. APAC Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 45. APAC Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 46. Europe Plasma-derived Medicinal Products Sales by Country (2018-2023) & (K Units)
Table 47. Europe Plasma-derived Medicinal Products Sales Market Share by Country (2018-2023)
Table 48. Europe Plasma-derived Medicinal Products Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Plasma-derived Medicinal Products Revenue Market Share by Country (2018-2023)
Table 50. Europe Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 51. Europe Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Plasma-derived Medicinal Products
Table 59. Key Market Challenges & Risks of Plasma-derived Medicinal Products
Table 60. Key Industry Trends of Plasma-derived Medicinal Products
Table 61. Plasma-derived Medicinal Products Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Plasma-derived Medicinal Products Distributors List
Table 64. Plasma-derived Medicinal Products Customer List
Table 65. Global Plasma-derived Medicinal Products Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Plasma-derived Medicinal Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Plasma-derived Medicinal Products Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Plasma-derived Medicinal Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Plasma-derived Medicinal Products Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Plasma-derived Medicinal Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Plasma-derived Medicinal Products Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Plasma-derived Medicinal Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Plasma-derived Medicinal Products Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Plasma-derived Medicinal Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Plasma-derived Medicinal Products Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Plasma-derived Medicinal Products Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Plasma-derived Medicinal Products Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Plasma-derived Medicinal Products Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Novartis(CSL Limited) Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis(CSL Limited) Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 81. Novartis(CSL Limited) Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Novartis(CSL Limited) Main Business
Table 83. Novartis(CSL Limited) Latest Developments
Table 84. Biotest AG (Creat Group Corporation) Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 86. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Biotest AG (Creat Group Corporation) Main Business
Table 88. Biotest AG (Creat Group Corporation) Latest Developments
Table 89. Grifols SA Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Grifols SA Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 91. Grifols SA Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Grifols SA Main Business
Table 93. Grifols SA Latest Developments
Table 94. Sigma-Aldrich Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Sigma-Aldrich Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 96. Sigma-Aldrich Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Sigma-Aldrich Main Business
Table 98. Sigma-Aldrich Latest Developments
Table 99. Thermo Fisher Scientific Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Thermo Fisher Scientific Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 101. Thermo Fisher Scientific Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Thermo Fisher Scientific Main Business
Table 103. Thermo Fisher Scientific Latest Developments
Table 104. Octapharma AG Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Octapharma AG Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 106. Octapharma AG Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Octapharma AG Main Business
Table 108. Octapharma AG Latest Developments
Table 109. Takeda Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 110. Takeda Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 111. Takeda Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Takeda Main Business
Table 113. Takeda Latest Developments
Table 114. Kedrion Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 115. Kedrion Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 116. Kedrion Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Kedrion Main Business
Table 118. Kedrion Latest Developments
Table 119. China Biologic Products Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 120. China Biologic Products Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 121. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. China Biologic Products Main Business
Table 123. China Biologic Products Latest Developments
Table 124. LFB Group Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 125. LFB Group Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 126. LFB Group Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. LFB Group Main Business
Table 128. LFB Group Latest Developments
Table 1. Plasma-derived Medicinal Products Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Plasma-derived Medicinal Products Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Immunoglobulins
Table 4. Major Players of Coagulation Factor Concentrates
Table 5. Major Players of Other
Table 6. Global Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 7. Global Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Table 8. Global Plasma-derived Medicinal Products Revenue by Type (2018-2023) & ($ million)
Table 9. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2023)
Table 10. Global Plasma-derived Medicinal Products Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 12. Global Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Table 13. Global Plasma-derived Medicinal Products Revenue by Application (2018-2023)
Table 14. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2018-2023)
Table 15. Global Plasma-derived Medicinal Products Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Plasma-derived Medicinal Products Sales by Company (2018-2023) & (K Units)
Table 17. Global Plasma-derived Medicinal Products Sales Market Share by Company (2018-2023)
Table 18. Global Plasma-derived Medicinal Products Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Plasma-derived Medicinal Products Revenue Market Share by Company (2018-2023)
Table 20. Global Plasma-derived Medicinal Products Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Plasma-derived Medicinal Products Producing Area Distribution and Sales Area
Table 22. Players Plasma-derived Medicinal Products Products Offered
Table 23. Plasma-derived Medicinal Products Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Plasma-derived Medicinal Products Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Plasma-derived Medicinal Products Sales Market Share Geographic Region (2018-2023)
Table 28. Global Plasma-derived Medicinal Products Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Plasma-derived Medicinal Products Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Plasma-derived Medicinal Products Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Plasma-derived Medicinal Products Sales Market Share by Country/Region (2018-2023)
Table 32. Global Plasma-derived Medicinal Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Plasma-derived Medicinal Products Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Plasma-derived Medicinal Products Sales by Country (2018-2023) & (K Units)
Table 35. Americas Plasma-derived Medicinal Products Sales Market Share by Country (2018-2023)
Table 36. Americas Plasma-derived Medicinal Products Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Plasma-derived Medicinal Products Revenue Market Share by Country (2018-2023)
Table 38. Americas Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 39. Americas Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 40. APAC Plasma-derived Medicinal Products Sales by Region (2018-2023) & (K Units)
Table 41. APAC Plasma-derived Medicinal Products Sales Market Share by Region (2018-2023)
Table 42. APAC Plasma-derived Medicinal Products Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Plasma-derived Medicinal Products Revenue Market Share by Region (2018-2023)
Table 44. APAC Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 45. APAC Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 46. Europe Plasma-derived Medicinal Products Sales by Country (2018-2023) & (K Units)
Table 47. Europe Plasma-derived Medicinal Products Sales Market Share by Country (2018-2023)
Table 48. Europe Plasma-derived Medicinal Products Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Plasma-derived Medicinal Products Revenue Market Share by Country (2018-2023)
Table 50. Europe Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 51. Europe Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Plasma-derived Medicinal Products
Table 59. Key Market Challenges & Risks of Plasma-derived Medicinal Products
Table 60. Key Industry Trends of Plasma-derived Medicinal Products
Table 61. Plasma-derived Medicinal Products Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Plasma-derived Medicinal Products Distributors List
Table 64. Plasma-derived Medicinal Products Customer List
Table 65. Global Plasma-derived Medicinal Products Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Plasma-derived Medicinal Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Plasma-derived Medicinal Products Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Plasma-derived Medicinal Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Plasma-derived Medicinal Products Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Plasma-derived Medicinal Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Plasma-derived Medicinal Products Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Plasma-derived Medicinal Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Plasma-derived Medicinal Products Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Plasma-derived Medicinal Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Plasma-derived Medicinal Products Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Plasma-derived Medicinal Products Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Plasma-derived Medicinal Products Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Plasma-derived Medicinal Products Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Novartis(CSL Limited) Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis(CSL Limited) Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 81. Novartis(CSL Limited) Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Novartis(CSL Limited) Main Business
Table 83. Novartis(CSL Limited) Latest Developments
Table 84. Biotest AG (Creat Group Corporation) Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 86. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Biotest AG (Creat Group Corporation) Main Business
Table 88. Biotest AG (Creat Group Corporation) Latest Developments
Table 89. Grifols SA Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Grifols SA Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 91. Grifols SA Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Grifols SA Main Business
Table 93. Grifols SA Latest Developments
Table 94. Sigma-Aldrich Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Sigma-Aldrich Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 96. Sigma-Aldrich Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Sigma-Aldrich Main Business
Table 98. Sigma-Aldrich Latest Developments
Table 99. Thermo Fisher Scientific Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Thermo Fisher Scientific Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 101. Thermo Fisher Scientific Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Thermo Fisher Scientific Main Business
Table 103. Thermo Fisher Scientific Latest Developments
Table 104. Octapharma AG Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Octapharma AG Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 106. Octapharma AG Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Octapharma AG Main Business
Table 108. Octapharma AG Latest Developments
Table 109. Takeda Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 110. Takeda Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 111. Takeda Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Takeda Main Business
Table 113. Takeda Latest Developments
Table 114. Kedrion Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 115. Kedrion Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 116. Kedrion Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Kedrion Main Business
Table 118. Kedrion Latest Developments
Table 119. China Biologic Products Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 120. China Biologic Products Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 121. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. China Biologic Products Main Business
Table 123. China Biologic Products Latest Developments
Table 124. LFB Group Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors
Table 125. LFB Group Plasma-derived Medicinal Products Product Portfolios and Specifications
Table 126. LFB Group Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. LFB Group Main Business
Table 128. LFB Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Plasma-derived Medicinal Products
Figure 2. Plasma-derived Medicinal Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma-derived Medicinal Products Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Plasma-derived Medicinal Products Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Plasma-derived Medicinal Products Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Immunoglobulins
Figure 10. Product Picture of Coagulation Factor Concentrates
Figure 11. Product Picture of Other
Figure 12. Global Plasma-derived Medicinal Products Sales Market Share by Type in 2022
Figure 13. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2023)
Figure 14. Plasma-derived Medicinal Products Consumed in Emergency Care
Figure 15. Global Plasma-derived Medicinal Products Market: Emergency Care (2018-2023) & (K Units)
Figure 16. Plasma-derived Medicinal Products Consumed in Epidemic Diseasae
Figure 17. Global Plasma-derived Medicinal Products Market: Epidemic Diseasae (2018-2023) & (K Units)
Figure 18. Plasma-derived Medicinal Products Consumed in Immune System Disorder
Figure 19. Global Plasma-derived Medicinal Products Market: Immune System Disorder (2018-2023) & (K Units)
Figure 20. Plasma-derived Medicinal Products Consumed in Antibody Deficiency
Figure 21. Global Plasma-derived Medicinal Products Market: Antibody Deficiency (2018-2023) & (K Units)
Figure 22. Plasma-derived Medicinal Products Consumed in Coagulation Disorder
Figure 23. Global Plasma-derived Medicinal Products Market: Coagulation Disorder (2018-2023) & (K Units)
Figure 24. Plasma-derived Medicinal Products Consumed in Others
Figure 25. Global Plasma-derived Medicinal Products Market: Others (2018-2023) & (K Units)
Figure 26. Global Plasma-derived Medicinal Products Sales Market Share by Application (2022)
Figure 27. Global Plasma-derived Medicinal Products Revenue Market Share by Application in 2022
Figure 28. Plasma-derived Medicinal Products Sales Market by Company in 2022 (K Units)
Figure 29. Global Plasma-derived Medicinal Products Sales Market Share by Company in 2022
Figure 30. Plasma-derived Medicinal Products Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Plasma-derived Medicinal Products Revenue Market Share by Company in 2022
Figure 32. Global Plasma-derived Medicinal Products Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Plasma-derived Medicinal Products Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Plasma-derived Medicinal Products Sales 2018-2023 (K Units)
Figure 35. Americas Plasma-derived Medicinal Products Revenue 2018-2023 ($ Millions)
Figure 36. APAC Plasma-derived Medicinal Products Sales 2018-2023 (K Units)
Figure 37. APAC Plasma-derived Medicinal Products Revenue 2018-2023 ($ Millions)
Figure 38. Europe Plasma-derived Medicinal Products Sales 2018-2023 (K Units)
Figure 39. Europe Plasma-derived Medicinal Products Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Plasma-derived Medicinal Products Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa Plasma-derived Medicinal Products Revenue 2018-2023 ($ Millions)
Figure 42. Americas Plasma-derived Medicinal Products Sales Market Share by Country in 2022
Figure 43. Americas Plasma-derived Medicinal Products Revenue Market Share by Country in 2022
Figure 44. Americas Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Figure 45. Americas Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Figure 46. United States Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Plasma-derived Medicinal Products Sales Market Share by Region in 2022
Figure 51. APAC Plasma-derived Medicinal Products Revenue Market Share by Regions in 2022
Figure 52. APAC Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Figure 53. APAC Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Figure 54. China Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Plasma-derived Medicinal Products Sales Market Share by Country in 2022
Figure 62. Europe Plasma-derived Medicinal Products Revenue Market Share by Country in 2022
Figure 63. Europe Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Figure 64. Europe Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Figure 65. Germany Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Figure 74. Egypt Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Plasma-derived Medicinal Products in 2022
Figure 80. Manufacturing Process Analysis of Plasma-derived Medicinal Products
Figure 81. Industry Chain Structure of Plasma-derived Medicinal Products
Figure 82. Channels of Distribution
Figure 83. Global Plasma-derived Medicinal Products Sales Market Forecast by Region (2024-2029)
Figure 84. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Plasma-derived Medicinal Products
Figure 2. Plasma-derived Medicinal Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma-derived Medicinal Products Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Plasma-derived Medicinal Products Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Plasma-derived Medicinal Products Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Immunoglobulins
Figure 10. Product Picture of Coagulation Factor Concentrates
Figure 11. Product Picture of Other
Figure 12. Global Plasma-derived Medicinal Products Sales Market Share by Type in 2022
Figure 13. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2018-2023)
Figure 14. Plasma-derived Medicinal Products Consumed in Emergency Care
Figure 15. Global Plasma-derived Medicinal Products Market: Emergency Care (2018-2023) & (K Units)
Figure 16. Plasma-derived Medicinal Products Consumed in Epidemic Diseasae
Figure 17. Global Plasma-derived Medicinal Products Market: Epidemic Diseasae (2018-2023) & (K Units)
Figure 18. Plasma-derived Medicinal Products Consumed in Immune System Disorder
Figure 19. Global Plasma-derived Medicinal Products Market: Immune System Disorder (2018-2023) & (K Units)
Figure 20. Plasma-derived Medicinal Products Consumed in Antibody Deficiency
Figure 21. Global Plasma-derived Medicinal Products Market: Antibody Deficiency (2018-2023) & (K Units)
Figure 22. Plasma-derived Medicinal Products Consumed in Coagulation Disorder
Figure 23. Global Plasma-derived Medicinal Products Market: Coagulation Disorder (2018-2023) & (K Units)
Figure 24. Plasma-derived Medicinal Products Consumed in Others
Figure 25. Global Plasma-derived Medicinal Products Market: Others (2018-2023) & (K Units)
Figure 26. Global Plasma-derived Medicinal Products Sales Market Share by Application (2022)
Figure 27. Global Plasma-derived Medicinal Products Revenue Market Share by Application in 2022
Figure 28. Plasma-derived Medicinal Products Sales Market by Company in 2022 (K Units)
Figure 29. Global Plasma-derived Medicinal Products Sales Market Share by Company in 2022
Figure 30. Plasma-derived Medicinal Products Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Plasma-derived Medicinal Products Revenue Market Share by Company in 2022
Figure 32. Global Plasma-derived Medicinal Products Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Plasma-derived Medicinal Products Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Plasma-derived Medicinal Products Sales 2018-2023 (K Units)
Figure 35. Americas Plasma-derived Medicinal Products Revenue 2018-2023 ($ Millions)
Figure 36. APAC Plasma-derived Medicinal Products Sales 2018-2023 (K Units)
Figure 37. APAC Plasma-derived Medicinal Products Revenue 2018-2023 ($ Millions)
Figure 38. Europe Plasma-derived Medicinal Products Sales 2018-2023 (K Units)
Figure 39. Europe Plasma-derived Medicinal Products Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Plasma-derived Medicinal Products Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa Plasma-derived Medicinal Products Revenue 2018-2023 ($ Millions)
Figure 42. Americas Plasma-derived Medicinal Products Sales Market Share by Country in 2022
Figure 43. Americas Plasma-derived Medicinal Products Revenue Market Share by Country in 2022
Figure 44. Americas Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Figure 45. Americas Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Figure 46. United States Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Plasma-derived Medicinal Products Sales Market Share by Region in 2022
Figure 51. APAC Plasma-derived Medicinal Products Revenue Market Share by Regions in 2022
Figure 52. APAC Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Figure 53. APAC Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Figure 54. China Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Plasma-derived Medicinal Products Sales Market Share by Country in 2022
Figure 62. Europe Plasma-derived Medicinal Products Revenue Market Share by Country in 2022
Figure 63. Europe Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Figure 64. Europe Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Figure 65. Germany Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Application (2018-2023)
Figure 74. Egypt Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Plasma-derived Medicinal Products Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Plasma-derived Medicinal Products in 2022
Figure 80. Manufacturing Process Analysis of Plasma-derived Medicinal Products
Figure 81. Industry Chain Structure of Plasma-derived Medicinal Products
Figure 82. Channels of Distribution
Figure 83. Global Plasma-derived Medicinal Products Sales Market Forecast by Region (2024-2029)
Figure 84. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Application (2024-2029)
